Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | RAD52 | P43351 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24622129 | 0.91 | KMT2A (0.51) | KMT2ALMNANR1I2AHR | |
| SCHEMBL5486033 | 0.84 | KMT2A (0.51) | KMT2ALMNA | |
| SCHEMBL25809366 | 0.83 | KMT2A (0.45) | KMT2ALMNANR1I2AHRCA12 | |
| SCHEMBL4874795 | 0.81 | KMT2A (0.57) | KMT2ALMNANR1I2AHRMAPT | |
| SCHEMBL987508 | 0.77 | KMT2A (0.66) | KMT2ALMNANR1I2AHRMAPT | |
| SCHEMBL20053796 | 0.77 | KMT2A (0.58) | KMT2ALMNANR1I2AHRPKM | |
| SCHEMBL13558679 | 0.77 | KMT2A (0.53) | KMT2ALMNANR1I2AHRPKM | |
| SCHEMBL616128 | 0.76 | KMT2A (0.74) | KMT2ALMNANR1I2AHRPKM | |
| SCHEMBL140123 | 0.75 | KMT2A (0.61) | KMT2ALMNANR1I2AHRPKM | |
| SCHEMBL17563553 | 0.74 | KMT2A (0.77) | KMT2ALMNANR1I2AHRPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702712-B2 | Cationic cyanuric chloride derivative tanning agent and preparation method thereof | SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702712-B2 | Cationic cyanuric chloride derivative tanning agent and preparation method thereof | C9, PROC, TYR | KMT2A 3823/4885LMNA 2491/4885NR1I2 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.